COMP <GO>
EPAM vs HNGE // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
EPAM Systems Inc. (NYSE) VS. Hinge Health Inc. (NYSE) • 15-METRIC TALLY: EPAM 7
— HNGE 4
■ METRIC PARITY
LAST: $143.80 (+2.34%) • MKT CAP: $7.25B
options-implied-move
—
LAST: $115.48 (+1.01%) • MKT CAP: $9.22B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EPAM VS. HNGE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EPAM | HNGE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 28.80% | 79.60% | -50.80 | HNGE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 17.10% | -35.00% | +52.10 | EPAM | /roic <GO> |
| EV/EBITDA & P/E Valuation | 10.2x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 8.82% | 1.81% | +7.01 | EPAM | /fcf-yield <GO> |
| Operating Margin | 9.50% | -60.00% | +69.50 | EPAM | /operating-margins <GO> |
| Net Profit Margin | 6.90% | -60.00% | +66.90 | EPAM | /net-margins <GO> |
| Revenue Growth (YoY) | 15.40% | 50.60% | -35.20 | HNGE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.67 | 12.12 | -6.45 | HNGE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 66.5 | 63.7 | +2.80 | EPAM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.37 | 1.24 | +0.13 | EPAM | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.5x | 29.0x | -13.50 | EPAM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.25B | $9.22B | -$1.98B | HNGE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EPAM REV | HNGE REV | EPAM GROSS % | HNGE GROSS % | EPAM FCF | HNGE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.46B | $587.9M | 28.8% | 79.6% | $612.7M | $170.7M |
| FY 2024 | $4.73B | $390.4M | 30.7% | 76.8% | $527.0M | $48.0M |
| FY 2023 | $4.69B | $292.7M | — | — | $351.6M | -$77.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EPAM // BETA 1.37
HNGE // BETA 1.24